Physician profile
Stephanie Frank
NPI 1679195770
$579.30
in general payments reported to CMS, 2019-2025
11 companies · $21.78 in 2025
The $21.78 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.18 · 2023: $358 · 2024: $157 · 2025: $21.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $148.45 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $141.94 | 2023 | Dexcom G7 Gss (161) |
| Idorsia Pharmaceuticals US INC | $85.91 | 2023-2024 | Quviviq |
| Phadia US INC. | $54.86 | 2023-2024 | Immunocap |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.67 | 2024 | Ofev |
| Integra Lifesciences Corporation | $22.30 | 2021 | |
| Astellas Pharma US INC | $21.38 | 2023 | Veozah |
| Amgen INC. | $20.45 | 2023 | Evenity, Prolia |
| Janssen Pharmaceuticals, INC | $19.88 | 2021 | |
| Novo Nordisk INC | $18.24 | 2023 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $15.22 | 2023 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Frank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.